405
Participants
Start Date
October 25, 2019
Primary Completion Date
May 28, 2021
Study Completion Date
July 16, 2021
MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL
Solution for injection in pre-filled pen, subcutaneous administration
MENOPUR powder and solvent for solution for injection, 75 IU
Solution for injection in vials (powder and diluent), subcutaneous administration
Placebo (for MENOPUR solution for injection in pre-filled pen)
Solution for injection in pre-filled pen, subcutaneous administration
Placebo (for MENOPUR powder and solvent for solution for injection)
Solution for injection in vials (powder and diluent); subcutaneous administration
Abington Reproductive Medicine, Abington
Carolina Conceptions, Raleigh
Reproductive Endocrinology Associates of Charlotte, Charlotte
Center for Reproductive Medicine, Winter Park
Fertility and IVF Center of Miami, Miami
Fertility Associates of Memphis, PLLC, Memphis
Institute for Reproductive Health, Cincinnati
InVia Fertility Specialists, SC, Hoffman Estates
Fertility Centers of Illinois, Chicago
Fertility Answers, LLC, Baton Rouge
OU Physicians Reproductive Medicine, Oklahoma City
Center for Assisted Reproduction, Bedford
Houston Fertility Institute, Houston
Center of Reproductive Medicine, Webster
Idaho Center for Reproductive Medicine, Boise
Fertility Treatment Center, Tempe
SIRM Fertility Center, Las Vegas
Fertility Specialists Medical Group - San Diego Center for Reproductive Surgery, San Diego
Center for Advanced Reproductive Services PC, Farmington
Yale Fertility Center, New Haven
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY